Volume 4, Emitir 7 (2014)
Resultados da Trilha Clínica
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Resultados da Trilha Clínica
Oral iron therapies in development for iron deficiency in chronic kidney disease
David William Mudge & David Wayne Johnson
Metodologia da Trilha Clínica
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Resultados da Trilha Clínica
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
